| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.41B | 38.84B | 38.54B | 38.08B | 37.27B | 34.64B |
| Gross Profit | 8.10B | 8.68B | 7.32B | 6.31B | 9.05B | 7.84B |
| EBITDA | 6.92B | 7.01B | 6.01B | 4.58B | 6.33B | 5.92B |
| Net Income | 2.51B | 2.56B | 1.59B | 855.00M | 3.73B | 2.18B |
Balance Sheet | ||||||
| Total Assets | 76.21B | 75.11B | 76.50B | 72.90B | 70.43B | 70.20B |
| Cash, Cash Equivalents and Short-Term Investments | 7.63B | 7.93B | 8.74B | 7.84B | 9.01B | 10.00B |
| Total Debt | 15.07B | 15.07B | 16.53B | 16.78B | 15.92B | 15.58B |
| Total Liabilities | 29.21B | 28.71B | 31.46B | 30.66B | 28.57B | 31.12B |
| Stockholders Equity | 47.00B | 46.40B | 45.05B | 42.24B | 41.87B | 39.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.19B | 897.00M | -1.32B | -3.04B | 942.00M |
| Operating Cash Flow | 0.00 | 6.37B | 6.15B | 1.49B | 1.98B | 5.22B |
| Investing Cash Flow | 0.00 | -5.07B | -4.41B | -2.82B | -3.08B | -3.54B |
| Financing Cash Flow | 0.00 | -2.42B | -870.00M | 102.00M | 120.00M | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥23.89B | 8.17 | ― | 3.21% | 9.61% | 173.72% | |
77 Outperform | ¥21.07B | 15.72 | ― | 3.63% | 18.02% | 18.04% | |
75 Outperform | ¥25.82B | 13.56 | ― | 2.47% | 3.53% | 8.36% | |
66 Neutral | ¥27.15B | 11.96 | ― | 3.84% | -3.41% | -12.83% | |
66 Neutral | ¥19.07B | 10.08 | ― | 3.23% | 13.09% | 89.45% | |
66 Neutral | ¥15.80B | 12.90 | ― | 2.78% | 1.30% | -5.03% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Nippon Chemical Industrial Co., Ltd. has announced that its board has approved the sale of three listed investment securities as part of a review of its cross-shareholdings to improve capital efficiency. The transactions, planned between December 25, 2025 and the end of March 2026, are expected to generate an estimated gain on sale of around 1 billion yen, which will be booked as extraordinary income in the consolidated results for the fiscal year ending March 2026, potentially bolstering earnings, while the company continues to review its full-year forecast and may update investors if disclosure becomes necessary.
The most recent analyst rating on (JP:4092) stock is a Hold with a Yen2725.00 price target. To see the full list of analyst forecasts on Nippon Chemical Industrial Co., Ltd. stock, see the JP:4092 Stock Forecast page.
Nippon Chemical Industrial Co., Ltd. has announced that its board of directors has approved the acquisition of up to 100,000 common shares, representing about 1.14% of its outstanding stock (excluding treasury shares), as treasury stock. The company plans to spend up to 260 million yen on market purchases via the Tokyo Stock Exchange between January 5 and March 31, 2026, with the stated aim of improving capital efficiency and enhancing shareholder returns, signaling a shareholder-friendly capital allocation policy that may support its share price and underline management’s confidence in the company’s financial position.
The most recent analyst rating on (JP:4092) stock is a Hold with a Yen2725.00 price target. To see the full list of analyst forecasts on Nippon Chemical Industrial Co., Ltd. stock, see the JP:4092 Stock Forecast page.
Nippon Chemical Industrial Co., Ltd. reported a slight increase in net sales for the six months ended September 30, 2025, but experienced a significant decline in operating and ordinary profits compared to the previous year. Despite these challenges, the company plans to increase its annual dividend per share, indicating confidence in its future financial stability.
The most recent analyst rating on (JP:4092) stock is a Buy with a Yen3123.00 price target. To see the full list of analyst forecasts on Nippon Chemical Industrial Co., Ltd. stock, see the JP:4092 Stock Forecast page.